Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(22%)
Results Posted
40%(2 trials)
Terminated
1(11%)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_2
3
33%

Phase Distribution

0

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
3(37.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(5)
Terminated(2)

Detailed Status

Completed5
Recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
83.3%
Most Advanced
Phase 2

Trials by Phase

Phase 23 (37.5%)
N/A5 (62.5%)

Trials by Status

terminated111%
completed556%
recruiting222%
withdrawn111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
9